Hostname: page-component-8448b6f56d-xtgtn Total loading time: 0 Render date: 2024-04-20T02:04:19.258Z Has data issue: false hasContentIssue false
  • English
  • Français

Variability in Vancomycin Use in Newborn Intensive Care Units Determined From Data in an Electronic Medical Record

Published online by Cambridge University Press:  02 January 2015

Cody Arnold ,
Reese Clark ,
Jaclyn Bosco ,
Craig Shoemaker  and
Alan R. Spitzer
Cody Arnold*
Affiliation:
Department of Neonatology, Baylor University Medical Center, Dallas, Texas Baylor Health Care System, Institute for Health Care Research and Improvement, Dallas, Texas Pediatrix-Obstetrix Center for Research and Education, Sunrise, Florida
Reese Clark
Affiliation:
Pediatrix-Obstetrix Center for Research and Education, Sunrise, Florida
Jaclyn Bosco
Affiliation:
Baylor Health Care System, Institute for Health Care Research and Improvement, Dallas, Texas Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts
Craig Shoemaker
Affiliation:
Department of Neonatology, Baylor University Medical Center, Dallas, Texas
Alan R. Spitzer
Affiliation:
Pediatrix-Obstetrix Center for Research and Education, Sunrise, Florida
*
Department of Neonatology, Baylor University Medical Center, 3500 Gaston Ave., 3 Hoblitzelle, Dallas, TX 75246 (CodyA@BaylorHealth.edu)
Get access Rights & Permissions [Opens in a new window]

Abstract

Data from an electronic medical record were used to demonstrate a large variation in the proportion of patients treated with vancomycin in 56 newborn intensive care units, which ranged from 18% to 70% . Use of oxacillin or nafcillin instead of vancomycin was rare during the first few years of the study period but was routine in 13% of the newborn intensive care units during the last fewyears of the study period. The use of electronic medical record data for studies of antibiotic use is discussed here.

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 29 , Issue 7 , July 2008 , pp. 667 - 670
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Stoll, BJ, Hansen, N, Fanaroff, AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002;110(Pt 1):285–291.Google Scholar
2.Clark, R, Powers, R, White, R, Bloom, B, Sanchez, P, Benjamin DK, Jr. Nosocomial infection in the NICU: a medical complication or unavoidable problem? J Perinatol 2004;24:382–388.Google Scholar
3.Krediet, TG, Jones, ME, Gerards, LJ, Fleer, A. Clinical outcome of cephalothin versus vancomycin therapy in the treatment of coagulase-negative staphylococcal septicemia in neonates: relation to methicillin resistance and mec Agene carriage of blood isolates. Pediatrics 1999;103:E29.CrossRefGoogle Scholar
4.Rubin, LG, Sanchez, PJ, Siegel, J, Levine, G, Saiman, L, Jarvis, WR. Evaluation and treatment of neonates with suspected late-onset sepsis: a survey of neonatologists' practices. Pediatrics 2002;110:e42.Google Scholar
5.Blayney, MP, Al Madani, M. Coagulase-negative staphylococcal infections in a neonatal intensive care unit: in vivo response to cloxacillin Paediatr Child Health 2006;11:659–663.Google Scholar
6.Karlowicz, MG, Buescher, ES, Surka, AE. Fulminant late-onset sepsis in a neonatal intensive care unit, 1988–1997, and the impact of avoiding empiric vancomycin therapy. Pediatrics 2000;106:1387–1390.CrossRefGoogle Scholar
7.Lam, JPH, Mitchell, SJ, Gore, C. Selective use of vancomycin for empirical treatment of neonatal sepsis: effects on clinical outcome and glycopeptide usage. Arch Dis Child 2001;84(Suppl 1):A10–A68.Google Scholar
8.Lawrence, SL, Roth, V, Slinger, R, Toye, B, Gaboury, I, Lemyre, B. Cloxacillin versus vancomycin for presumed late-onset sepsis in the neonatal intensive care unit and the impact on outcome of coagulase negative staphylococcal bacteremia: a retrospective cohort study. BMC Pediatr 2005;5:49.Google Scholar
9.Benjamin, DK, DeLong, E, Cotten, CM, Garges, HP, Steinbach, WJ, Clark, RH. Mortality following blood culture in premature infants: increased with Gram-negative bacteremia and candidemia, but not Gram-positive bacteremia. J Perinatol 2004;24:175–180.Google Scholar
10.Healy, CM, Hulten, KG, Palazzi, DL, Campbell, JR, Baker, CJ. Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Clin Infect Dis 2004;39:1460–1466.CrossRefGoogle Scholar
11.Healy, CM, Palazzi, DL, Edwards, MS, Campbell, JR, Baker, CJ. Features of invasive staphylococcal disease in neonates. Pediatrics 2004;114:953–961.Google Scholar
12.Iezzoni, LI. Risk Adjustment for Measuring Health Care Outcomes. Ann Arbor, MI: Health Administration Press; 1994.Google Scholar